Number of participants with adverse events after first vaccination 28 days after the first vaccination [clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205]

Number of participants with adverse events after first vaccination 28 days after the first vaccination [clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205]

To evaluate the adverse events of EV71 vaccine in healthy children and infants after first vaccination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205
A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants [clinicaltrials:NCT01313715]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Number of participants with adverse events after first vaccination 28 days after the first vaccination [clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205]

To evaluate the adverse events of EV71 vaccine in healthy children and infants after first vaccination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205
Bio2RDF identifier
10f3e4ccb131bc4b288814848863b205
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205
measure [clinicaltrials_vocabulary:measure]
Number of participants with adverse events after first vaccination
time frame [clinicaltrials_vocabulary:time-frame]
28 days after the first vaccination
description
To evaluate the adverse events ...... nfants after first vaccination
identifier
clinicaltrials_resource:10f3e4ccb131bc4b288814848863b205
title
Number of participants with ad ...... ys after the first vaccination
@en
inDataset
type
label
Number of participants with ad ...... 3e4ccb131bc4b288814848863b205]
@en